EFFECTS OF ADRENERGIC NEURONE-BLOCKING AGENTS ON THE SUBMAXILLARY GLAND OF THE CAT.
D018663:Adrenergic Agents; D018674:Adrenergic Antagonists; D001285:Atropine; D001949:Bretylium Compounds; D002415:Cats; D002814:Chorda Tympani Nerve; D004983:Ethanolamines; D005453:Fluorescence; D006145:Guanethidine; D008853:Microscopy; D008856:Microscopy, Fluorescence; D009431:Neural Conduction; D009482:Neurophysiology; D010600:Pharmacology; D012106:Research; D012472:Salivation; D013363:Submandibular Gland; D013565:Sympatholytics; D014665:Vasodilator Agents
D018663:Adrenergic Agents; D018674:Adrenergic Antagonists; D001949:Bretylium Compounds; D004983:Ethanolamines; D013565:Sympatholytics; D014665:Vasodilator Agents; D001285:Atropine; C084832:pronethalol; D006145:Guanethidine
ATROPINE; BRETYLIUM COMPOUNDS; CATS; CHORDA TYMPANI NERVE; EXPERIMENTAL LAB STUDY; GUANETHIDINE; MICROSCOPY, FLUORESCENCE; NEURAL CONDUCTION; NEUROPHYSIOLOGY; PHARMACOLOGY; PRONETHALOL; SALIVATION; SUBMANDIBULAR GLAND; SYMPATHOLYTICS; VASODILATOR AGENTS